Synthesis and Structure−Activity Relationship of Acrylamides as KCNQ2 Potassium Channel Openers
- 16 April 2004
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 47 (11) , 2887-2896
- https://doi.org/10.1021/jm0305826
Abstract
A new class of acrylamides was synthesized, and the effects of these analogues on outward potassium current were evaluated by using two electrode voltage clamp recordings from Xenopus laevis oocytes expressing cloned mKCNQ2 channels. SAR studies indicated that the pharmacophore of the acrylamide series includes the (S) absolute configuration at the (1-phenyl)ethyl moiety and the α,β-unsaturated acrylamide functionality with a free NH. This study identified (S)-N-[1-(3-morpholin-4-yl-phenyl)-ethyl]-3-phenyl-acrylamide ((S)-1) and (S)-N-[1-(4-fluoro-3-morpholin-4-yl-phenyl)-ethyl]-3-(4-fluoro-phenyl)-acrylamide ((S)-2) as KCNQ2 openers for further electrophysiological evaluations. These two acrylamides demonstrated significant activity in the cortical spreading depression model of migraine as we reported previously.Keywords
This publication has 8 references indexed in Scilit:
- KCNQ/M Currents in Sensory Neurons: Significance for Pain TherapyJournal of Neuroscience, 2003
- The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic painEuropean Journal of Pharmacology, 2003
- Activation of Expressed KCNQ Potassium Currents and Native Neuronal M-Type Potassium Currents by the Anti-Convulsant Drug RetigabineJournal of Neuroscience, 2001
- The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2/3 subunitsNeuroscience Letters, 2000
- Hydrochloric Acid Catalysis of N-Bromosuccinimide (NBS) Mediated Nuclear Aromatic Brominations in AcetoneSynthetic Communications, 2000
- Linkage of ATM to Cell Cycle Regulation by the Chk2 Protein KinaseScience, 1998
- Rational Development of Practical Catalysts for Aromatic Carbon−Nitrogen Bond FormationAccounts of Chemical Research, 1998
- A Randomized, Controlled Trial of Linopirdine in the Treatment of Alzheimer's DiseaseCanadian Journal of Neurological Sciences, 1997